Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
The Canadian Journal of Cardiology|May 26, 2020
Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS TrialChao Gao, Piotr Buszman, Paweł Buszman, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2019
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trialKuniaki Takahashi, Ply Chichareon, Rodrigo Modolo, et al.
JACC. Cardiovascular Interventions|March 7, 2020
DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCIPly Chichareon, Rodrigo Modolo, Hideyuki Kawashima, et al.
JACC. Cardiovascular Interventions|September 30, 2019
Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel DiseaseNorihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, et al.
The Canadian Journal of Cardiology|March 7, 2020
Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERSAna Paula de Faria, Rodrigo Modolo, Ply Chichareon, et al.
Lancet (London, England)|September 1, 2018
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx, Marco Valgimigli, Peter Jüni, et al.
Journal of the American Heart Association|March 1, 2022
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS TrialFelice Gragnano, Marcel Zwahlen, Pascal Vranckx, et al.
European Heart Journal|August 10, 2019
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trialPatrick W Serruys, Kuniaki Takahashi, Ply Chichareon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2019
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trialPatrick W Serruys, Mariusz Tomaniak, Ply Chichareon, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 16, 2020
Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trialHironori Hara, Norihiro Kogame, Kuniaki Takahashi, et al.
Pageof 9